ARIAD PHARMACEUTICALS INC
Healthcare · Biological Products, (No Diagnostic Substances) · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|---|
| Revenue | $118.8M | $105.4M | $45.6M | $558,000 | $25.3M | $179.0M |
| Operating income | −$217.3M | −$160.2M | −$273.6M | −$205.1M | −$76.8M | $104.9M |
| Net income | −$231.2M | −$162.6M | −$274.2M | −$220.9M | −$123.6M | $85.2M |
| Total assets | $546.7M | $603.1M | $370.9M | $180.2M | $320.7M | $120.0M |
| Total liabilities | $649.8M | $522.3M | — | — | — | — |
| Equity | −$103.1M | $80.8M | $185.5M | $112.9M | $220.1M | $64.1M |
| EPS (diluted) | — | — | — | $-1.34 | $-0.93 | $0.74 |
| Shares out. | 187.5M | 186.3M | 183.8M | 158.9M | 157.6M | 126.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2015- Operating margin
- −182.9%
- Net margin
- −194.6%
- Return on equity
- 224.1%
- Return on assets
- −42.3%
- Return on capital (ROCE)
- −52.4%
- Liabilities / assets
- 118.9%
- Debt / equity
- —
- Book value / share
- $-0.55
- Revenue growth (YoY)
- 12.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2015- Altman Z″ (distress)
- -9.74distress
- Accruals / assets
- −13.2%clean
- Beneish M-Score
- -2.33normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventFeb 16, 2017
- Other material eventFeb 6, 2017
- Entered a material agreement · Terminated a material agreement · Regulation FD disclosure · Other material eventJan 10, 2017
- Other material eventDec 8, 2016
- Director / officer changeDec 7, 2016
- Other material eventNov 30, 2016
- Other material eventNov 18, 2016
- Results of operations · Item 5.08 · Regulation FD disclosure · Other material eventNov 7, 2016
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4FORM 4Oct 15, 2021
- 3FORM 3Oct 15, 2021
- SC 13G/AWESTFIELD CAPITAL MANAGEMENT COMPANY, L.P.Apr 7, 2017
- CT ORDERFeb 27, 2017
- 15-12BFeb 27, 2017
- SC 13D/AAMENDMENT NO. 9Feb 21, 2017
- S-8 POSFeb 16, 2017
- S-8 POSFeb 16, 2017
- S-8 POSFeb 16, 2017
- S-8 POSFeb 16, 2017
- S-8 POSFeb 16, 2017
- S-8 POSFeb 16, 2017
- S-8 POSFeb 16, 2017
- S-8 POSFeb 16, 2017
- S-8 POSFeb 16, 2017
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.